EA201071202A1 - Индолы в качестве модуляторов никотинового рецептора ацетилхолина подтипа альфа-7 - Google Patents

Индолы в качестве модуляторов никотинового рецептора ацетилхолина подтипа альфа-7

Info

Publication number
EA201071202A1
EA201071202A1 EA201071202A EA201071202A EA201071202A1 EA 201071202 A1 EA201071202 A1 EA 201071202A1 EA 201071202 A EA201071202 A EA 201071202A EA 201071202 A EA201071202 A EA 201071202A EA 201071202 A1 EA201071202 A1 EA 201071202A1
Authority
EA
Eurasian Patent Office
Prior art keywords
indols
models
nicotine receptor
acetylcholine alpha
receptor acetylcholine
Prior art date
Application number
EA201071202A
Other languages
English (en)
Other versions
EA017726B1 (ru
Inventor
Кевин Диннелл
Эндрю П. Лайтфут
Говард Роберт Маршалл
Original Assignee
Глэксо Груп Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0807050A external-priority patent/GB0807050D0/en
Priority claimed from GB0810229A external-priority patent/GB0810229D0/en
Application filed by Глэксо Груп Лимитед filed Critical Глэксо Груп Лимитед
Publication of EA201071202A1 publication Critical patent/EA201071202A1/ru
Publication of EA017726B1 publication Critical patent/EA017726B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Данное изобретение относится к модуляции никотинового α7-рецептора ацетилхолина (nAChR) с помощью соединения из перечня А или его соли, которое может представлять собой N-[(2-трифторметил-1H-индол-5-ил)метил]-5-(трифторметил)-2-пиримидинкарбоксамид.
EA201071202A 2008-04-17 2009-04-16 Индолы в качестве модуляторов никотинового рецептора ацетилхолина подтипа альфа-7 EA017726B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0807050A GB0807050D0 (en) 2008-04-17 2008-04-17 Novel compounds
GB0810229A GB0810229D0 (en) 2008-06-04 2008-06-04 Novel compounds
PCT/EP2009/054495 WO2009127679A1 (en) 2008-04-17 2009-04-16 Indoles as modulators of nicoticic acetylcholine receptor subtype alpha-7

Publications (2)

Publication Number Publication Date
EA201071202A1 true EA201071202A1 (ru) 2011-06-30
EA017726B1 EA017726B1 (ru) 2013-02-28

Family

ID=40791353

Family Applications (2)

Application Number Title Priority Date Filing Date
EA201071201A EA018113B1 (ru) 2008-04-17 2009-04-16 Индолы в качестве модуляторов никотинового рецептора ацетилхолина подтипа альфа-71
EA201071202A EA017726B1 (ru) 2008-04-17 2009-04-16 Индолы в качестве модуляторов никотинового рецептора ацетилхолина подтипа альфа-7

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EA201071201A EA018113B1 (ru) 2008-04-17 2009-04-16 Индолы в качестве модуляторов никотинового рецептора ацетилхолина подтипа альфа-71

Country Status (19)

Country Link
US (2) US8283365B2 (ru)
EP (2) EP2279184B1 (ru)
JP (2) JP2011516599A (ru)
KR (2) KR20100133016A (ru)
CN (2) CN102066356B (ru)
AR (1) AR071203A1 (ru)
AU (2) AU2009237650B2 (ru)
BR (2) BRPI0911682A2 (ru)
CA (2) CA2725441C (ru)
CL (1) CL2009000916A1 (ru)
EA (2) EA018113B1 (ru)
ES (2) ES2392796T3 (ru)
IL (2) IL208575A (ru)
MX (2) MX2010011359A (ru)
PE (1) PE20091724A1 (ru)
TW (1) TW201004939A (ru)
UY (1) UY31769A1 (ru)
WO (2) WO2009127678A1 (ru)
ZA (2) ZA201006856B (ru)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010004177A (es) 2007-10-18 2010-05-03 Janssen Pharmaceutica Nv 1,2,4-triazoles trisustituidos.
JO2784B1 (en) 2007-10-18 2014-03-15 شركة جانسين فارماسوتيكا ان. في 5,3,1 - Triazole substitute derivative
ES2479440T3 (es) 2008-01-30 2014-07-24 Cephalon, Inc. Derivados de piridazina sustituidos que tienen actividad antagonista de histamina H3
AR070936A1 (es) 2008-03-19 2010-05-12 Janssen Pharmaceutica Nv 1,2,4 -triazoles trisustituidos
AR071763A1 (es) 2008-05-09 2010-07-14 Janssen Pharmaceutica Nv Pirazoles trisustituidos, composiciones farmaceuticas que los contienen, y usos de los mismos en el tratamiento de trastornos neurologicos y psiquiatricos
CA2758772A1 (en) * 2009-04-16 2010-10-21 Proximagen Limited Indole derivative modulators of the alpha 7 nachr
TWI558398B (zh) 2009-09-22 2016-11-21 諾華公司 菸鹼乙醯膽鹼受體α７活化劑之用途
GB201012686D0 (en) * 2010-07-28 2010-09-15 Glaxo Group Ltd Novel compounds
JO3078B1 (ar) * 2009-11-27 2017-03-15 Janssen Pharmaceutica Nv مورفولينوثيازولات بصفتها منظمات الوستيرية نوع الفا 7 موجبة
AU2012213086B2 (en) 2011-02-03 2016-05-05 Lupin Limited Pyrrole derivatives used as modulators of alpha7 nAChR
EA024170B1 (ru) 2011-02-23 2016-08-31 Люпин Лимитед ГЕТЕРОАРИЛЬНЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ МОДУЛЯТОРОВ nAChR АЛЬФА7
CA2830458A1 (en) * 2011-03-18 2012-09-27 Novartis Ag Combinations of alpha 7 nicotinic acetylcholine receptor activators and mglur5 antagonists for use in dopamine induced dyskinesia in parkinson's disease
US9187420B2 (en) 2011-03-31 2015-11-17 Lupin Limited Pyrrole derivatives as nicotinic acetylcholine receptor modulators for use in the treatment of neurodegenerative disorders such as alzheimer's and parkinson's disease
TW201245185A (en) 2011-04-01 2012-11-16 Lundbeck & Co As H New positive allosteric modulators of nicotinic acetylcholine receptor
WO2013005153A1 (en) 2011-07-05 2013-01-10 Lupin Limited Biaryl derivatives as nachr modulators
IN2014MN01756A (ru) 2012-03-06 2015-07-03 Lupin Ltd
EP2846803B1 (en) * 2012-05-08 2017-06-21 Alpharmagen, LLC Alpha 7 nicotinic acetylcholine receptor allosteric modulators, their derivatives and uses thereof
EP2905279A4 (en) * 2012-10-02 2016-04-20 Sumitomo Dainippon Pharma Co Ltd imidazole
EP2945936A1 (en) 2012-11-12 2015-11-25 Lupin Limited Thiazole derivatives as alpha 7 nachr modulators
CN103006642B (zh) * 2013-01-04 2014-10-22 中国药科大学 一类炔亚甲基吲哚-2-酮类衍生物的用途
EP2945941B1 (en) 2013-01-16 2016-12-07 Lupin Limited Pyrrole derivatives as alpha 7 nachr modulators
US10058310B2 (en) 2013-03-13 2018-08-28 Ethicon Llc Electrosurgical device with drum-driven articulation
WO2014141091A1 (en) 2013-03-13 2014-09-18 Lupin Limited Pyrrole derivatives as alpha 7 nachr modulators
TW201446243A (zh) 2013-06-03 2014-12-16 Lupin Ltd 4-(5-(4-氯苯基)-2-(2-環丙基乙醯基)-1,4-二甲基-1氫-吡咯-3-基)苯磺醯胺作為α7尼古丁乙醯膽鹼受體調節劑
CA2913987A1 (en) 2013-06-17 2014-12-24 Lupin Limited Pyrrole derivatives as alpha 7 nachr modulators
JP6738797B2 (ja) * 2014-03-25 2020-08-12 イーエムアイシーアイピーアイ・エルエルシーＥｍｉｃｉｐｉ Ｌｌｃ レット症候群治療薬
JP6870304B2 (ja) * 2016-12-05 2021-05-12 住友電気工業株式会社 半導体装置の製造方法
WO2018110669A1 (en) 2016-12-15 2018-06-21 Ono Pharmaceutical Co., Ltd. Activator of trek (twik related k+ channels) channels
HU231333B1 (hu) 2018-07-13 2023-01-28 Richter Gedeon Nyrt Spirokromán származékok
HU231414B1 (hu) 2018-07-13 2023-08-28 Richter Gedeon Nyrt. Tiadiazin származékok
HU231478B1 (hu) 2018-07-13 2024-02-28 Richter Gedeon Nyrt. Szubsztituált (aza)indol származékok
KR20220113431A (ko) * 2019-12-02 2022-08-12 스톰 테라퓨틱스 리미티드 Mettl3 저해제로서의 폴리헤테로환식 화합물
CN111285792B (zh) * 2020-03-23 2023-05-02 三峡大学 2-取代吲哚化合物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9903997D0 (sv) * 1999-11-03 1999-11-03 Astra Ab New compounds
GB0403155D0 (en) * 2004-02-12 2004-03-17 Vernalis Res Ltd Chemical compounds
KR20100124272A (ko) * 2008-02-07 2010-11-26 아보트 러보러터리즈 양성 알로스테릭 조절제로서의 아미드 유도체 및 이의 사용방법

Also Published As

Publication number Publication date
UY31769A1 (es) 2009-09-30
CL2009000916A1 (es) 2010-12-31
ES2392795T3 (es) 2012-12-13
MX2010011359A (es) 2010-11-12
BRPI0911682A2 (pt) 2015-10-13
EA018113B1 (ru) 2013-05-30
WO2009127678A1 (en) 2009-10-22
ZA201006856B (en) 2011-06-29
EP2279184B1 (en) 2012-08-08
EP2279183A1 (en) 2011-02-02
IL208574A0 (en) 2010-12-30
KR20100133016A (ko) 2010-12-20
US8377941B2 (en) 2013-02-19
CN102066357B (zh) 2014-04-09
US8283365B2 (en) 2012-10-09
IL208575A (en) 2014-04-30
EA017726B1 (ru) 2013-02-28
IL208574A (en) 2014-04-30
CN102066357A (zh) 2011-05-18
US20110028486A1 (en) 2011-02-03
AU2009237650B2 (en) 2012-05-31
ZA201006855B (en) 2011-06-29
CA2725441C (en) 2014-05-27
CA2721630A1 (en) 2009-10-22
AU2009237649B2 (en) 2012-07-26
EP2279183B1 (en) 2012-08-08
KR20100135911A (ko) 2010-12-27
JP2011516599A (ja) 2011-05-26
US20110034515A1 (en) 2011-02-10
CN102066356B (zh) 2014-06-11
AU2009237649A1 (en) 2009-10-22
BRPI0910585A2 (pt) 2015-09-22
WO2009127679A1 (en) 2009-10-22
EP2279184A1 (en) 2011-02-02
JP2011516598A (ja) 2011-05-26
TW201004939A (en) 2010-02-01
CN102066356A (zh) 2011-05-18
CA2725441A1 (en) 2009-10-22
ES2392796T3 (es) 2012-12-13
AU2009237650A1 (en) 2009-10-22
EA201071201A1 (ru) 2011-04-29
PE20091724A1 (es) 2009-12-06
IL208575A0 (en) 2010-12-30
AR071203A1 (es) 2010-06-02
MX2010011358A (es) 2010-11-10

Similar Documents

Publication Publication Date Title
EA201071202A1 (ru) Индолы в качестве модуляторов никотинового рецептора ацетилхолина подтипа альфа-7
PH12015500119B1 (en) Composition for controlling plant disease and application therefor
WO2009128963A3 (en) Cross-neutralizing human monoclonal antibodies to sars-cov and methods of use thereof
CL2007002268A1 (es) Procedimiento de preparacion de compuestos derivados de ciclopropilamina opticamente activo; compuesto intermediario derivado de 2-aril ciclopropancarboxamida opticamente activo.
WO2015048484A3 (en) Binding moieties for biofilm remediation
EA200901157A1 (ru) Конденсированные кольцевые гетероциклические модуляторы киназы
CL2014000814A1 (es) Compuestos derivados de piridazinona; composicion herbicida que los comprende; y metodo para controlar malezas.
DK2504322T3 (da) Fremgangsmåde til fremstilling af 5,5-disubstituerede 4,5-dihydroisoxazol-3-thiocarboxamidinsalte
CL2008000355A1 (es) Procedimiento de preparacion de un compuesto derivado de 1-metil-2-fenilamino metil-1h-benzoimidazol-5-amida; compuesto intermediario hidrobromuro.
EA201001696A1 (ru) СОЕДИНЕНИЯ ХИНУКЛИДИНА В КАЧЕСТВЕ ЛИГАНДОВ НИКОТИНОВОГО АЦЕТИЛХОЛИНОВОГО РЕЦЕПТОРА α7
EA201001847A1 (ru) Соединения и композиции, применяемые для лечения малярии
EA201391318A1 (ru) Твердые формы 3-(5-амино-2-метил-4-оксо-4н-хиназолин-3-ил)пиперидин-2,6-диона и их фармацевтические композиции и применение
DK2504005T3 (da) Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme
UA112281C2 (uk) Стабільні інсектицидні композиції і способи їх отримання
CA2830549C (en) Methods and compositions for preparing noribogaine from voacangine
GEP20156318B (en) Heteroaryl derivatives as alpha7 nachr modulators
CR20110432A (es) Pirimidinas fusionadas
EA201590330A1 (ru) Соли и твердые формы (s)-3-(4-((4-(морфолинометил)бензил)окси)-1-оксоизоиндолин-2-ил)пиперидин-2,6-диона и включающие их композиции и способы их применения
EA201300946A1 (ru) Асимметричные мочевины и их медицинское применение
EA201490756A1 (ru) Разагилина цитрамид
CL2014000815A1 (es) Compuestos derivados de 2-metoxibenzamidas insecticidas; composiciones insecticidas.
DK2378864T3 (da) Fremgangsmåde til opdræt af høns.
ITRM20090019A1 (it) Composizione pesticida.
MA39347B2 (fr) Protéines de fusion d'uti
PH12014502749A1 (en) Arthropod pest control composition and arthropod pest control method

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY RU